CO2024010803A2 - Compuestos de tienopirrolotriazina, su preparación y su uso terapéutico - Google Patents
Compuestos de tienopirrolotriazina, su preparación y su uso terapéuticoInfo
- Publication number
- CO2024010803A2 CO2024010803A2 CONC2024/0010803A CO2024010803A CO2024010803A2 CO 2024010803 A2 CO2024010803 A2 CO 2024010803A2 CO 2024010803 A CO2024010803 A CO 2024010803A CO 2024010803 A2 CO2024010803 A2 CO 2024010803A2
- Authority
- CO
- Colombia
- Prior art keywords
- thienopyrrolotriazine
- compounds
- preparation
- therapeutic use
- formula
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D495/14—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Neurology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP22315036 | 2022-02-21 | ||
| PCT/EP2023/054138 WO2023156643A1 (en) | 2022-02-21 | 2023-02-20 | Thienopyrrolotriazine compounds, their preparation and their therapeutic use |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CO2024010803A2 true CO2024010803A2 (es) | 2024-08-20 |
Family
ID=81326677
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CONC2024/0010803A CO2024010803A2 (es) | 2022-02-21 | 2024-08-08 | Compuestos de tienopirrolotriazina, su preparación y su uso terapéutico |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20250129091A1 (https=) |
| EP (1) | EP4482841A1 (https=) |
| JP (1) | JP2025506729A (https=) |
| KR (1) | KR20240151767A (https=) |
| CN (1) | CN118843632A (https=) |
| AU (1) | AU2023222186A1 (https=) |
| CA (1) | CA3244475A1 (https=) |
| CO (1) | CO2024010803A2 (https=) |
| IL (1) | IL314781A (https=) |
| MX (1) | MX2024010216A (https=) |
| WO (1) | WO2023156643A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116375728B (zh) * | 2021-12-31 | 2025-06-10 | 成都赜灵生物医药科技有限公司 | 噻吩吡咯并三嗪酮类化合物及其用途 |
| WO2025153532A1 (en) | 2024-01-16 | 2025-07-24 | NodThera Limited | Nlrp3 inhibitors and glp-1 agonists combination therapies |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20210038877A (ko) * | 2018-07-25 | 2021-04-08 | 노파르티스 아게 | Nlrp3 인플라마좀 억제제 |
| JP2023523418A (ja) * | 2020-04-23 | 2023-06-05 | ヤンセン ファーマシューティカ エヌ.ベー. | Nlrp3の阻害剤としての三環式化合物 |
-
2023
- 2023-02-20 JP JP2024549135A patent/JP2025506729A/ja active Pending
- 2023-02-20 IL IL314781A patent/IL314781A/en unknown
- 2023-02-20 CN CN202380021421.XA patent/CN118843632A/zh active Pending
- 2023-02-20 EP EP23705039.8A patent/EP4482841A1/en active Pending
- 2023-02-20 WO PCT/EP2023/054138 patent/WO2023156643A1/en not_active Ceased
- 2023-02-20 MX MX2024010216A patent/MX2024010216A/es unknown
- 2023-02-20 AU AU2023222186A patent/AU2023222186A1/en active Pending
- 2023-02-20 US US18/834,987 patent/US20250129091A1/en active Pending
- 2023-02-20 CA CA3244475A patent/CA3244475A1/en active Pending
- 2023-02-20 KR KR1020247027615A patent/KR20240151767A/ko active Pending
-
2024
- 2024-08-08 CO CONC2024/0010803A patent/CO2024010803A2/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IL314781A (en) | 2024-10-01 |
| KR20240151767A (ko) | 2024-10-18 |
| US20250129091A1 (en) | 2025-04-24 |
| JP2025506729A (ja) | 2025-03-13 |
| MX2024010216A (es) | 2024-09-02 |
| CN118843632A (zh) | 2024-10-25 |
| EP4482841A1 (en) | 2025-01-01 |
| CA3244475A1 (en) | 2023-08-24 |
| WO2023156643A1 (en) | 2023-08-24 |
| AU2023222186A1 (en) | 2024-10-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO2024010803A2 (es) | Compuestos de tienopirrolotriazina, su preparación y su uso terapéutico | |
| UY38793A (es) | Compuestos químicos | |
| MX2022005839A (es) | Compuestos utiles como inhibidores de la proteina helios. | |
| CL2024002183A1 (es) | Compuestos de benzopirimidina y usos de estos | |
| PY1923494A (es) | Derivados de n-(3-(7h-pirrolo[2,3-d]pirimidin-4-il)fenil)benzamida | |
| CR20220251A (es) | Nuevos derivados de metilquinazolinona | |
| UY27381A1 (es) | 2-tio-3,5-diciano-4-fenil-6-aminopiridinas sustituidas y su uso | |
| ECSP21026485A (es) | Piridazinonas y sus métodos de uso | |
| BRPI0510177B8 (pt) | composto, composição farmacêutica e uso do mesmo | |
| CY1112453T1 (el) | Αντιϊικες ενωσεις | |
| UY27571A1 (es) | 2-tio-3, 5-diciano-4-fenil-6-aminopiridinas sustituidas y su uso | |
| BR112022003982A2 (pt) | Compostos heterocíclicos | |
| MX2023007265A (es) | Inhibidores de cdk y su uso como productos farmacéuticos. | |
| CO2023000056A2 (es) | Derivados de amidopirimidona | |
| MX2022001449A (es) | Compuestos de aminoesterol humano ent-03, composiciones relacionadas que comprenden los mismos y metodos para usar los mismos. | |
| BR112022003357A2 (pt) | Compostos heterocíclicos | |
| PY2021592A (es) | Arilamidinas fungicidas | |
| EA200600605A1 (ru) | Перегруппированные пентанолы, способ их получения и их применение в качестве противовоспалительных средств | |
| CL2025002125A1 (es) | Compuestos novedosos | |
| CO2025012210A2 (es) | Polimorfo como inhibidor de la proteína quinasa mek, método de preparación y uso del mismo | |
| ECSP034754A (es) | Derivados de beta-carbolina y su uso farmaceutico contra depresion y ansiedad | |
| AR132654A1 (es) | Arilamidinas fungicidas | |
| CL2024001073A1 (es) | Inhibidores de la replicación del virus de inmunodeficiencia humana | |
| EA200602281A1 (ru) | Гетероарилсульфоны и сульфонамиды и их терапевтические применения | |
| MX2025000791A (es) | Compuestos terapeuticos, formulaciones y uso de los mismos |